The fight against Covid-19: The risk impacts on healthcare
Covid-19 has presented life science companies around the world with a set of new and evolving challenges.
As we are now seeing members of the public receiving a vaccination, Stephanie Bristow, Class Underwriter, Healthcare London, London Wholesale at AXA XL, discusses the new risks life sciences companies are facing and how risk engineering and transfer is playing a part in helping to manage them.
More on Health Insurance and Protection
Browse categories
Back to Top
Back to Top